Scleroderma: Lung

Mycophenolate led to improvements in patients with systemic sclerosis-related interstitial lung disease

Image result for scleroderma lung

Compared with placebo, treatment with mycophenolate was linked with improvements in physiologic…

A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease

Rituximab (RTX) may favorably affect lung function and skin fibrosis in patients with systemic sclerosis (SSc). We aimed to assess long-term efficacy and safety of RTX in SSc compared to standard treatment.

Stem Cell Transplant Preferred over Cyclophosphamide for Severe Scleroderma

Myeloablative autologous hematopoietic stem cell…